BMS Consensus Statements: Summary & Practice Points
Title: Primary prevention of coronary heart disease in women
Article: » print
this
Primary prevention of coronary heart disease in women
British Menopause Society Council Consensus statement
Margaret Rees and John Stevenson on behalf of the British Menopause
Society Council 27 November 2007
Summary
The British Menopause Society Council is committed to provide up to date
authoritative reviews to aid health professionals to inform and advise women
about key issues in postreproductive health. Coronary heart disease (CHD) is
a leading cause of death in women. Observational studies have consistently
shown estrogen to help prevent CHD in postmenopausal women. The large randomized
controlled Women’s Health Initiative (WHI) trial did not confirm these
observational findings. However, further analyses of the WHI study as
well as the observational Nurses’ Health Study have now found that the
timing of onset of hormone replacement therapy (HRT) use is important and that
estrogen may have a protective role in CHD in women aged 50 -59 years. This
consensus statement will examine the evidence regarding HRT and non-estrogen
therapies (lipid lowering agents, aspirin, antihypertensives, antidiabetic
medications, SERMs) as well as diet, lifestyle and smoking cessation in the
primary and secondary prevention of CHD in women.
Summary practice points
- estrogen may have a protective role in CHD prevention in women aged 50
-59 years
- women with a premature menopause should take estrogen to reduce
the risk of CHD
- the role of lipid-lowering agents is uncertain
- aspirin cannot be recommended
for primary prevention of CHD, but may protect against stroke
- treating hypertension
reduces the risk of CHD
- in diabetics, prevention of CHD is based on management
of established cardiovascular risk factors through both lifestyle measures
and pharmacotherapy
- in metabolic syndrome, prevention of CHD is based on management
of established cardiovascular risk factors through both lifestyle measures
and pharmacotherapy
- stopping smoking, reducing obesity, improving diet and
undertaking regular exercise are key lifestyle measures
The full statement, scientific papers, charts, presentations etc are available in the members area. » Join here
« go back
|